Clal Biotechnology | CBI - Loan Capital


Clal Biotechnology reported ILS25.96M in Loan Capital for its fiscal quarter ending in December of 2023.





Loan Capital Change Date
aTyr Pharma USD 12.51M 12.11M Dec/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
RedHill Biopharma USD 190K 0 Jun/2024
TherapeuticsMD USD 0 0 Mar/2022